Phase II trial using combination of oxaliplatin, capecitabine, and celecoxib with concurrent radiation in patients with operable rectal cancer.

e14117 Background: Achieving complete pathological response (CPR) with neoadjuvant chemoradiation may predict a higher likelihood of long-term survival in patients with operable rectal cancer. Howe...